手机版澳门黄金城网址

The 10th biological medicine industry technology seminar of zhongyuan company Beijing station was successfully held

On August 2, 2018, Beijing zhongyuan company 10th biological medicine industry technology seminar Beijing station was successfully held in xingji pullman hotel, yizhuang, Beijing.Conference invited Sartorius, BD, Alfa Laval, MD, Sciex, Luminex, Filtrox and other international well-known company's technical experts, for biomedical research and development and production of the entire process required for new products and new technology (including clarification filtration, capillary electrophoresis technology, multiple detection technology, large-scale cultivation technology of high density) conducted a wonderful speech.The conference attracted more than 100 professionals from biomedical enterprises and scientific research institutions in Beijing and its surrounding areas, and established a good communication platform for the r&d and production of various enterprises.

He yaoqiang, general manager of industrial business of zhongyuan company, attended the meeting and gave a speech

Shen Liang, Regulatory Affairs Manager of Sartorius China, gave a keynote speech on "One-time system regulations and industry standard updates"

Mr. Yan Tianci, senior engineer of BD's senior biotechnology department, gave a keynote speech on "vaccine market analysis and BHK serum-free medium development"

Wu Hao, Regional Sales Manager of Alfa Laval, gave a keynote speech on "The Application of Butterfly Centrifuge in Biopharmaceuticals"

Yin Di, MD product line manager of MD company, gave a keynote speech on "The road to compliance, where to go - a new generation of microplate detection system to help biopharmaceuticals"

Gao Tei,Sciex's biopharmaceuticals technical expert,  gave a keynote speech on "Properties in Biopharmaceutical Glucose Analysis - Capillary Electrophoresis for Rapid Glycine Preparation and Identification"

Chen Kunliang,Luminex's field application expert , gave a keynote speech on "New Choices with Multiple Benefits - Multiple Detection Technology"

Zhu Xican, the chief scientist of Beijing Zhongyuan Company, gave a keynote speech on “Developing the industrialization process and escorting the pharmaceutical industry upgrade”, sharing the experience of the popular cell therapy preparation process.

He Qun, Marketing Director of Filtrox, gave a keynote speech on “Clarification Filtration of High Density Culture/Fermentation Broth”

During the meeting, the first prize, the second prize and the third prize were also selected. The winners took a group photo with the participants.

Zhongyuan company is committed to building a platform for communication and exchange between domestic biomedical enterprises and foreign well-known enterprises.With continuous efforts, the biomedical industry technology seminar has developed into a meeting with a certain influence in the field of biomedicine in China, and become a platform for exchanges and cooperation between Chinese enterprises in the field of biotechnology and medicine.Zhongyuan will, as always, join hands with domestic biopharmaceutical enterprises to jointly promote the sustainable, healthy and rapid development of China's bio-pharmaceutical industry and play a positive role in promoting China's bio-pharmaceutical industry.

附件:
 
qy88.vip千嬴国际手机登录beplay体育网页版乐天堂官方网站